Dark

Check out our Dark Pool Levels

LPTX
Leap Therapeutics, Inc. Common Stock
stock NASDAQ

Inactive

Nov 12, 2025

2.05USD+368.571%(+1.61)785,997,614

Pre-market

0.00USD-100.000%(-0.44)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

07:11AM EST Leica Biosystems , Leap Therapeutics Partner On Companion Diagnostic To Advance Care For Cancer Patients RTTNews

07:01AM EST Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to PR Newswire

Jan 24, 2022

07:01AM EST Leap Therapeutics to Present at B. Riley Securities Oncology Investor Conference PR Newswire

Jan 19, 2022

07:40AM EST The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data Benzinga

Jan 18, 2022

05:02PM EST Leap Therapeutics To Present New Data From DisTinGuish Study Of DKN-01 Plus Tislelizumab At The ASCO GI Cancers Symposium Benzinga

05:01PM EST Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of PR Newswire

Jan 5, 2022

07:01AM EST Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference PR Newswire

Jan 3, 2022

07:01AM EST Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference PR Newswire

Nov 15, 2021

07:01AM EST Leap Therapeutics to Participate at the Piper Sandler 33rd Annual Virtual PR Newswire

Nov 12, 2021

07:26AM EST Leap Therapeutics Q3 EPS $(0.14) Down From $(0.09) YoY Benzinga

07:03AM EST Leap Therapeutics Q3 Loss Per Share $0.14 Vs Loss $0.09 Last Year RTTNews

07:01AM EST Leap Therapeutics Reports Third Quarter 2021 Financial Results PR Newswire

Oct 4, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2021 Benzinga

06:08AM EDT Mizuho Initiates Coverage On Leap Therapeutics with Buy Rating, Announces Price Target of $6 Benzinga

Oct 1, 2021

11:15AM EDT Looking Into Leap Therapeutics's Return On Capital Employed Benzinga

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 29, 2021

05:27AM EDT Leap Therapeutics 10%+ Owner Beigene Reported Purchase of 2,543,800 Shares @ Avg Price of $2.85/Share in Form 4 Filing on Wednesday Benzinga

Sep 24, 2021

12:01PM EDT Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire

Sep 23, 2021

07:57AM EDT The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data Benzinga

Sep 22, 2021

08:35AM EDT Leap Therapeutics Announces Pricing Of $90 Mln Of Common Stock And Pre-Funded Warrants RTTNews

08:31AM EDT Leap Therapeutics Announces Pricing of $90 million of Common Stock and PR Newswire

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

Sep 21, 2021

04:31PM EDT Hearing Leap Therapeutics Shares Are Said To Be Offered At $2.75-$2.85/Share Benzinga

04:28PM EDT Leap Therapeutics Shares Are Said To Be Offered At $2.75-$2.85/Share Benzinga

04:02PM EDT Leap Therapeutics Announces Proposed Public Offering of Common Stock And Pre-Funded Warrants Benzinga

04:01PM EDT Leap Therapeutics Announces Proposed Public Offering of Common Stock and PR Newswire

Sep 16, 2021

03:27PM EDT Why Leap Therapeutics Shares Are Trading Higher Today Benzinga

02:46PM EDT Mid-Afternoon Market Update: Dow Falls 70 Points; Aerie Pharmaceuticals Shares Plunge Benzinga

12:38PM EDT Mid-Day Market Update: Gold Drops Over 2%; Leap Therapeutics Shares Jump Benzinga

07:48AM EDT The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study Benzinga

06:36AM EDT The following are some of the stocks making big moves in Thursday's pre-market trading (as of 6.20 A.M. EDT). RTTNews

03:42AM EDT Leap Therapeutics, Inc. (LPTX), a biotechnology company focused on targeted and immuno-oncology therapeutics, announced Thursday updated positive data from the DisTinGuish Study of DKN-01 Plus Tislelizumab. RTTNews

02:59AM EDT Leap: DKN-01 Plus Tislelizumab & Chemotherapy Show Activity In Patients With Gastric Or Gastroesophageal Junction Cancer RTTNews

02:31AM EDT Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of PR Newswire

Sep 14, 2021

06:07AM EDT A Peek Into The Markets: US Stock Futures Mostly Flat Ahead Of Consumer Price Index Benzinga

04:33AM EDT Raymond James Maintains Outperform on Leap Therapeutics, Raises Price Target to $4 Benzinga

Sep 13, 2021

06:10AM EDT The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.45 A.M. EDT). RTTNews

06:08AM EDT Leap Therapeutics To Present New Data From DisTinGuish Study Of DKN-01 Plus Tislelizumab At ESMO 2021 Congress Benzinga

06:01AM EDT Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus PR Newswire

Sep 7, 2021

07:01AM EDT Leap Therapeutics to Participate at Two Upcoming Virtual Investor Conferences PR Newswire

Aug 13, 2021

07:07AM EDT Leap Therapeutics Q2 Loss Per Share $0.12, Flat With Prior Year RTTNews

07:03AM EDT Leap Therapeutics Q2 EPS $(0.12), Same YoY, Sales $375.00K, Same YoY Benzinga

07:01AM EDT Leap Therapeutics Reports Second Quarter 2021 Financial Results and Upcoming PR Newswire

Jul 26, 2021

07:01AM EDT Leap Therapeutics to Present at the ESMO 2021 Virtual Congress PR Newswire

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 16, 2021

07:37AM EDT The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study Benzinga

Jul 14, 2021

07:48AM EDT The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues Benzinga

Jul 7, 2021

07:01AM EDT Leap Therapeutics to Present at Ladenburg Thalmann 2021 Virtual Healthcare PR Newswire

Jun 14, 2021

07:01AM EDT Leap Therapeutics to Present at Raymond James 2021 Virtual Human Health PR Newswire

May 14, 2021

08:21AM EDT Leap Therapeutics Q1 EPS $(0.12) Up From $(0.55) YoY Benzinga

08:10AM EDT Leap Therapeutics Q1 Loss Per Share $0.12 Vs Loss Per Share $0.55 Year Ago RTTNews

08:01AM EDT Leap Therapeutics Reports First Quarter 2021 Financial Results PR Newswire

May 12, 2021

08:08AM EDT Leap Therapeutics And Flagship Biosciences Develops An Image Analysis RNAscope Assay RTTNews

08:03AM EDT Leap Therapeutics And Flagship Biosciences Announce They Have Developed Image Analysis RNAscope Assay For Prospective Trial Enrollment Benzinga

08:01AM EDT Leap Therapeutics and Flagship Biosciences Develop Image Analysis RNAscope PR Newswire

Apr 12, 2021

08:20AM EDT Flagship Biosciences, Leap Therapeutics Announce Deal For Tumor Expression Assay Utilizing RNAscope And Image Analysis RTTNews

08:01AM EDT Flagship Biosciences and Leap Therapeutics Announce Partnership and Approach PR Newswire

Apr 1, 2021

07:04AM EDT Leap Therapeutics Announces Completion of Enrollment for First-Line Patient Cohort in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Gastric or Gastroesophageal Junction Cancer Benzinga

07:01AM EDT Cohort in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Gastric or Gastroesophageal Junction Cancer PR Newswire

Mar 25, 2021

10:26AM EDT Leap Therapeutics Shares Quiet Following World Intellectual Property Portal Patent Scope Listing For 'USE OF DKK-1 INHIBITORS FOR TREATING CANCER' Benzinga

Mar 22, 2021

08:09AM EDT Leap Therapeutics Stock Is Trading Higher After Encouraging DKN-01 Data At Gynecologic Oncology Meet Benzinga

06:20AM EDT Leap Therapeutics Presented DKN-01 Clinical Data at the Society of Gynecologic Oncology 2021 Annual Meeting on Women's Cancer; Said DKN-01 Monotherapy Demonstrated Clinical Activity in Patients with Endometrial Cancer Benzinga

06:02AM EDT Leap Therapeutics Presents DKN-01 Clinical Data At Society Of Gynecologic Oncology 2021 Meeting On Women's Cancer RTTNews

06:02AM EDT Leap Therapeutics Presents DKN-01 Clinical Data at the Society of Gynecologic Oncology 2021 Annual Meeting on Women's Cancer Benzinga

06:01AM EDT Leap Therapeutics Presents DKN-01 Clinical Data at the Society of Gynecologic PR Newswire

Mar 19, 2021

07:46AM EDT The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs Benzinga

Mar 14, 2021

08:14AM EDT Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations Benzinga

Mar 12, 2021

07:02AM EST Leap Therapeutics Q4 Loss Per Share $0.09 Vs Loss $0.33 Last Year RTTNews

07:02AM EST Leap Therapeutics Q4 EPS $(0.09) Up From $(0.32) YoY Benzinga

07:01AM EST Leap Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results PR Newswire

Mar 2, 2021

07:26AM EST Raymond James Maintains Outperform on Leap Therapeutics, Raises Price Target to $3.5 Benzinga

Feb 22, 2021

07:01AM EST Leap Therapeutics to Present at Upcoming Virtual Investor Conferences PR Newswire

Jan 6, 2021

07:01AM EST Leap Therapeutics to Present at H.C. Wainwright BioConnect 2021 Conference PR Newswire

Jan 4, 2021

07:01AM EST Leap Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference PR Newswire

Dec 22, 2020

10:27AM EST Leap Therapeutics Reports Publication Of DKN-01 Mechanism Of Action Data In Molecular Cancer Research RTTNews

10:18AM EST Leap Therapeutics Announces Publication Of DKN-01 Mechanism Of Action Data In Molecular Cancer Research Benzinga

10:18AM EST Leap Therapeutics Announces Publication of DKN-01 Mechanism of Action Data in PR Newswire

Nov 23, 2020

07:01AM EST Leap Therapeutics to Participate at Piper Sandler 32nd Annual Virtual PR Newswire

Nov 12, 2020

07:37AM EST Leap Therapeutics Q3 Net Loss $7.1 Mln Vs. Net Loss $7.9 Mln Last Year RTTNews

07:20AM EST Leap Therapeutics Q3 EPS $(0.09) Up From $(0.33) YoY, Sales $375.00K Benzinga

07:01AM EST Leap Therapeutics Reports Third Quarter 2020 Financial Results PR Newswire

Nov 10, 2020

07:01AM EST Leap Therapeutics to Present at Stifel 2020 Healthcare Conference PR Newswire

Nov 9, 2020

10:00AM EST Leap Therapeutics Presents DKN-01 Monotherapy Data RTTNews

09:31AM EST Leap Therapeutics Presents DKN-01 Monotherapy Data At AACR Virtual Special Endometrial Cancer Conference Benzinga

09:31AM EST Leap Therapeutics Presents DKN-01 Monotherapy Data at AACR Virtual Special PR Newswire

08:45AM EST Leap Therapeutics Highlights Presentation Of Updated Data For DKN-01 In Esophagogastric Cancer Patients At Society for Immunotherapy Of Cancer Meeting Benzinga

08:12AM EST Leap Therapeutics Presents Updated Data For DKN-01 In Esophagogastric Cancer Patients RTTNews

08:02AM EST Leap Therapeutics Presents Updated Data for DKN-01 in Esophagogastric Cancer PR Newswire

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Oct 15, 2020

07:11AM EDT Leap Therapeutics To Present Esophagogastric Cancer Data At SITC 2020 Annual Meeting Nov. 9 Benzinga

07:01AM EDT Leap Therapeutics to Present Esophagogastric Cancer Data at SITC 2020 Annual PR Newswire

Sep 24, 2020

07:15AM EDT Leap : FDA Fast Track Designation Granted To DKN-01 For Treatment Of Gastric And Gastroesophageal Junction Cancer RTTNews

07:13AM EDT Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer Benzinga

07:01AM EDT Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for PR Newswire

Sep 21, 2020

07:09AM EDT Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer Benzinga

07:06AM EDT Leap Therapeutics And BeiGene Says First Patient Dosed In DisTinGuish Study RTTNews

07:01AM EDT in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer PR Newswire

Sep 14, 2020

05:31PM EDT Leap Therapeutics S-3 Shows Registration For $150M Mixed Securities Offering Benzinga

Sep 9, 2020

07:01AM EDT Leap Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment PR Newswire

Aug 24, 2020

07:01AM EDT Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans PR Newswire

Aug 17, 2020

07:25AM EDT HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Lowers Price Target to $4 Benzinga

Aug 13, 2020

07:08AM EDT Leap Therapeutics Q2 Loss Per Share $0.12 Vs Loss $0.37 Last Year RTTNews

07:07AM EDT Leap Therapeutics Q2 EPS $(0.12) Up From $(0.37) YoY, Sales $375.00K Benzinga

07:01AM EDT Leap Therapeutics Reports Second Quarter 2020 Financial Results PR Newswire

Share